Independent and combined effects of acute physiological hyperglycaemia and hyperinsulinaemia on metabolic gene expression in human skeletal muscle. 2013

Kostas Tsintzas, and Luke Norton, and Kamal Chokkalingam, and Nusrat Nizamani, and Scott Cooper, and Francis Stephens, and Rudolf Billeter, and Andrew Bennett
School of Biomedical Sciences, Nottingham University Medical School, Queens Medical Centre, Nottingham NG7 2UH, UK. Kostas.Tsintzas@nottingham.ac.uk

Physiological hyperglycaemia and hyperinsulinaemia are strong modulators of gene expression, which underpins some of their well-known effects on insulin action and energy metabolism. The aim of the present study was to examine whether acute in vivo exposure of healthy humans to hyperinsulinaemia and hyperglycaemia have independent or additive effects on expression of key metabolic genes in skeletal muscle. On three randomized occasions, seven young subjects underwent a 4 h (i) hyperinsulinaemic (50 m-units·m⁻²·min⁻¹) hyperglycaemic (10 mmol/l) clamp (HIHG), (ii) hyperglycaemic (10 mmol/l) euinsulinaemic (5 m-units·m⁻²·min⁻¹) clamp (LIHG) and (iii) hyperinsulinaemic (50 m-units·m⁻²·min⁻¹) euglycaemic (4.5 mmol/l) clamp (HING). Muscle biopsies were obtained before and after each clamp for the determination of expression of genes involved in energy metabolism, and phosphorylation of key insulin signalling proteins. Hyperinsulinaemia and hyperglycaemia exerted independent effects with similar direction of modulation on PI3KR1 (phosphatidylinositol 3-kinase, regulatory 1), LXRα (liver X receptor α), PDK4 (pyruvate dehydrogenase kinase 4) and FOXO1 (forkhead box O1A) and produced an additive effect on PI3KR1, the gene that encodes the p85α subunit of PI3K in human skeletal muscle. Acute hyperglycaemia itself altered the expression of genes involved in fatty acid transport and oxidation [fatty acid transporter (CD36), LCAD (long-chain acyl-CoA dehydrogenase) and FOXO1], and lipogenesis [LXRα, ChREBP (carbohydrate-responseelement-binding protein), ABCA1 (ATP-binding cassette transporter A1) and G6PD (glucose-6-phosphate dehydrogenase). Surperimposing hyperinsulinaemia on hyperglycaemia modulated a number of genes involved in insulin signalling, glucose metabolism and intracellular lipid accumulation and exerted an additive effect on PI3KR1. These may be early molecular events that precede the development of glucolipotoxicity and insulin resistance normally associated with more prolonged periods of hyperglycaemia and hyperinsulinaemia.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D004734 Energy Metabolism The chemical reactions involved in the production and utilization of various forms of energy in cells. Bioenergetics,Energy Expenditure,Bioenergetic,Energy Expenditures,Energy Metabolisms,Expenditure, Energy,Expenditures, Energy,Metabolism, Energy,Metabolisms, Energy
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006946 Hyperinsulinism A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS. Compensatory Hyperinsulinemia,Endogenous Hyperinsulinism,Exogenous Hyperinsulinism,Hyperinsulinemia,Hyperinsulinemia, Compensatory,Hyperinsulinism, Endogenous,Hyperinsulinism, Exogenous
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Kostas Tsintzas, and Luke Norton, and Kamal Chokkalingam, and Nusrat Nizamani, and Scott Cooper, and Francis Stephens, and Rudolf Billeter, and Andrew Bennett
August 1994, Acta physiologica Scandinavica,
Kostas Tsintzas, and Luke Norton, and Kamal Chokkalingam, and Nusrat Nizamani, and Scott Cooper, and Francis Stephens, and Rudolf Billeter, and Andrew Bennett
May 2008, American journal of physiology. Endocrinology and metabolism,
Kostas Tsintzas, and Luke Norton, and Kamal Chokkalingam, and Nusrat Nizamani, and Scott Cooper, and Francis Stephens, and Rudolf Billeter, and Andrew Bennett
February 2008, Diabetic medicine : a journal of the British Diabetic Association,
Kostas Tsintzas, and Luke Norton, and Kamal Chokkalingam, and Nusrat Nizamani, and Scott Cooper, and Francis Stephens, and Rudolf Billeter, and Andrew Bennett
December 1993, Scandinavian journal of clinical and laboratory investigation,
Kostas Tsintzas, and Luke Norton, and Kamal Chokkalingam, and Nusrat Nizamani, and Scott Cooper, and Francis Stephens, and Rudolf Billeter, and Andrew Bennett
January 2012, PloS one,
Kostas Tsintzas, and Luke Norton, and Kamal Chokkalingam, and Nusrat Nizamani, and Scott Cooper, and Francis Stephens, and Rudolf Billeter, and Andrew Bennett
May 2005, Journal of applied physiology (Bethesda, Md. : 1985),
Kostas Tsintzas, and Luke Norton, and Kamal Chokkalingam, and Nusrat Nizamani, and Scott Cooper, and Francis Stephens, and Rudolf Billeter, and Andrew Bennett
March 2010, Clinical and experimental pharmacology & physiology,
Kostas Tsintzas, and Luke Norton, and Kamal Chokkalingam, and Nusrat Nizamani, and Scott Cooper, and Francis Stephens, and Rudolf Billeter, and Andrew Bennett
January 1987, VASA. Supplementum,
Kostas Tsintzas, and Luke Norton, and Kamal Chokkalingam, and Nusrat Nizamani, and Scott Cooper, and Francis Stephens, and Rudolf Billeter, and Andrew Bennett
January 1988, VASA. Zeitschrift fur Gefasskrankheiten,
Kostas Tsintzas, and Luke Norton, and Kamal Chokkalingam, and Nusrat Nizamani, and Scott Cooper, and Francis Stephens, and Rudolf Billeter, and Andrew Bennett
January 2005, Acta physiologica Scandinavica,
Copied contents to your clipboard!